Minerva Neurosciences Inc (NERV)
2.37
+0.02
(+0.85%)
USD |
NASDAQ |
May 03, 16:00
2.41
+0.04
(+1.69%)
After-Hours: 20:00
Minerva Neurosciences Cash from Investing (Quarterly): 0.00 for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -0.0163M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 3.00M |
| June 30, 2020 | 4.50M |
| March 31, 2020 | 17.03M |
| December 31, 2019 | -2.312M |
| September 30, 2019 | 19.58M |
| June 30, 2019 | 7.366M |
| March 31, 2019 | -10.55M |
| December 31, 2018 | -27.43M |
| September 30, 2018 | 29.50M |
| Date | Value |
|---|---|
| June 30, 2018 | 36.10M |
| March 31, 2018 | 31.32M |
| December 31, 2017 | -0.0239M |
| September 30, 2017 | -79.80M |
| June 30, 2017 | -10.89M |
| March 31, 2017 | -16.48M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 8.375M |
| June 30, 2016 | 1.40M |
| March 31, 2016 | 8.043M |
| December 31, 2015 | 4.05M |
| September 30, 2015 | 0.828M |
| June 30, 2015 | -23.20M |
| March 31, 2015 | -0.005M |
| December 31, 2014 | -0.0469M |
| September 30, 2014 | -0.0337M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 1.168M |
| December 31, 2013 | -0.0032M |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-2.312M
Minimum
Dec 2019
19.58M
Maximum
Sep 2019
2.587M
Average
--
Median
Dec 2020
Cash from Investing (Quarterly) Benchmarks
| Viking Therapeutics Inc | -459.79M |
| Janux Therapeutics Inc | 11.12M |
| ACADIA Pharmaceuticals Inc | -0.347M |
| Karyopharm Therapeutics Inc | 26.84M |
| Calidi Biotherapeutics Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.991M |
| Free Cash Flow | -14.78M |
| Free Cash Flow Per Share (Quarterly) | -0.7904 |
| Free Cash Flow Yield | -95.97% |